Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Mid- to Long-term Outcomes of Aptis Distal Radioulnar Joint Arthroplasty: A Systematic Review of Studies With Minimum 5-Year Follow-up.

Created on 15 Sep 2026

Authors

Anderson Lee, Robert B Ponce, Abdul Khan, Claire Huff, Quinn Steiner, Sunishka Wimalawansa

Published in

Hand (New York, N.Y.). Pages 15589447261483187. Sep 15, 2026. Epub Sep 15, 2026.

Abstract

Total distal radioulnar joint (DRUJ) arthroplasty with the Aptis prosthesis is an increasingly used salvage procedure for refractory DRUJ pathology, though prior studies often rely on mean rather than minimum follow-up, limiting assessment of true mid- to long-term durability. This systematic review evaluated implant survivorship, complications, and functional outcomes following total DRUJ arthroplasty with a minimum follow-up of 60 months. A systematic review of PubMed, Embase, and Cochrane databases was performed, including patients who underwent total DRUJ arthroplasty with reported survivorship or complication data and a minimum of 60-month follow-up. Seven studies met the inclusion criteria, comprising 66 implants meeting the follow-up threshold. Implant survivorship at final follow-up was 96.0%, with an overall complication rate of 51.0% and reoperation rate of 44.9%; the most common complications were extensor carpi ulnaris tendonitis, heterotopic ossification, and hardware loosening. Weighted mean postoperative supination and pronation were 74° and 78°, respectively, with mean grip strength of 29 kg. Outcome scores demonstrated meaningful improvement. Total DRUJ arthroplasty shows appropriate mid- to long-term implant survivorship and satisfactory functional gains, though complication and reoperation rates warrant cautious interpretation. It remains a viable salvage option in appropriately selected patients, underscoring the need for thorough preoperative counseling.

PMID:
42742107
Bibliographic data and abstract were imported from PubMed on 15 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 27
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement